PharmiWeb.com - Global Pharma News & Resources
28-Mar-2019

Lyophilized Injectable Drugs Market Surge at 6.9% CAGR and Hit $ 4,350.3 Million by 2026

Acumen Research and Consulting present a new research report titled "Lyophilized Injectable Drugs Market (By Packaging Type: Specialty Packaging, Point-Of-Care Reconstitution, Single-Use Vials, Others; By Type of Delivery: Single-step Devices, Multi-step Devices, Prefilled Diluent Syringes, Proprietary Reconstitution Devices; By Indication: Infectious Diseases, Autoimmune Diseases, Metabolic Conditions, Others; By End-user: Ambulatory Surgical Centers, Hospitals, Specialty Clinics, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026" that includes the analysis of the various segments of this market across the important regions in the world.

The globallyophilized injectable drugs market sizeis anticipated to around USD 4,350.3 Million by 2026, this market is anticipated to grow with 6.9% CAGR during the forecast time period. Rise in health awareness and extensive usage of this drugs as a quick drying method is projected to drive the growth of the global lyophilized injectable drugs market.

Free Download Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1191

Lyophilization is a freeze drying method which is used for water removal from the material to extend its stability and shelf life. The products that are processed under lyophilization, output products are freezed under high vacuum that is majorly used for application in pharmaceutical industries for manufacturing high quality and affordable products. The global lyophilized injectable drugs market is driven by rise in chronic health conditions, increase in elderly population suffering from cardiac diseases and advancement in drying technologies. Furthermore, lyophilization process allows safe transfer of materials to the end users. Rise in alternative method to injectable drugs can restrain the growth of lyophilized injectable drugs market. Lyophilized injectable drugs is easy to transfer as it strengthens the stability of material and offers high quality products as compared to xconventional drying methods. This transformation from conventional drying method to advanced freezed drying technologies is one of the growth enablers of global lyophilized injectable drugs market over the coming years.

Lyophilized injectable drugs are safer and effective in administration of materials as compared to dried products. Owing to which the demand for lyophilized injectable drugs market is expected to grow in near future. High quality and longer shelf life of lyophilized injectable drugs has created growth opportunities for manufacturers to implement lyophilization process in the product manufacturing processes. The contract manufacturing and research services are in huge demand that offers lyophilized injectable drugs to offer high quality products to the end users. Therefore, huge presence of contract research manufacturing services is anticipated to bolster the growth of global lyophilized injectable drugs market.

The global lyophilized injectable drugs market is segmented into five main segment that include packaging type, type of delivery, indication, end-user and region. On the basis of packaging type, the global lyophilized injectable drugs market is segmented into specialty packaging, point-of-care reconstitution, single-use vials, and others. On the basis of type of delivery, the global lyophilized injectable drugs market is segmented into single-step devices, multi-step devices, prefilled diluent syringes, and proprietary reconstitution devices. On the basis of indication, the global lyophilized injectable drugs market is segmented into infectious diseases, autoimmune diseases, metabolic conditions, and others. On the basis of the end-user, the global lyophilized injectable drugs market is segmented into ambulatory surgical centers, hospitals, specialty clinics, and others. On the basis of region, the global lyophilized injectable drugs market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East amp; Africa.

View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/lyophilized-injectable-drugs-market

North America is expected to dominate the global lyophilized injectable drugs market and accounted for major share in 2017. The market is expected to lose share to the developing economies of Asia Pacific region. The widespread adoption of lyophilized injectable drugs for various application in end use industries is attributed to create opportunities in the region. The specialty packaging segment is growing rapidly due to the introduction of advanced packaging solutions which is one of the major factors expected to drive the growth of lyophilized injectable drugs market in the near future.

The rise in improved healthcare infrastructure in developing countries such as Singapore, India and Malaysia is expected to create growth opportunities for manufacturers in healthcare industry. This factors is anticipated to boost the demand in the regional market over the coming years.

The prominent players in the global lyophilized injectable drugs market are Schott AG, CIRON Drugs amp; Pharmaceuticals Pvt. Ltd, Mylan N.V., Baxter, Vetter Pharma, Dickinson and Company, SHL Group, B. Braun Melsungen AG, Jubilant HollisterStier, and others. The key vendors in the global lyophilized injectable drugs market are focusing on product launch and partnership strategy with an aim to capture large market share and gain in the lyophilized injectable drugs market. Also, the increase in availability of contract manufacturing and research is expected to offer lucrative opportunities for the key vendors in the gobal market.

Browse More Press Releases, Click Here:https://www.acumenresearchandconsulting.com/press-releases

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Lyophilized Injectable Drugs
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Lyophilized Injectable Drugs Market By Packaging Type
1.2.2.1. Global Lyophilized Injectable Drugs Market Revenue and Growth Rate Comparison By Packaging Type (2015-2026)
1.2.2.2. Global Lyophilized Injectable Drugs Market Revenue Share By Packaging Type in 2017
1.2.2.3. Specialty Packaging
1.2.2.4. Point-Of-Care Reconstitution
1.2.2.5. Single-Use Vials
1.2.2.6. Others
1.2.3. Lyophilized Injectable Drugs Market By Type of Delivery
1.2.3.1. Global Lyophilized Injectable Drugs Market Revenue and Growth Rate Comparison By Type of Delivery (2015-2026)
1.2.3.2. Global Lyophilized Injectable Drugs Market Revenue Share By Type of Delivery in 2017
1.2.3.3. Single-step Devices
1.2.3.4. Multi-step Devices
1.2.3.5. Prefilled Diluent Syringes
1.2.3.6. Proprietary Reconstitution Devices
1.2.4. Lyophilized Injectable Drugs Market By Indication
1.2.4.1. Global Lyophilized Injectable Drugs Market Revenue and Growth Rate Comparison By Indication (2015-2026)
1.2.4.2. Global Lyophilized Injectable Drugs Market Revenue Share By Indication in 2017
1.2.4.3. Infectious Diseases
1.2.4.4. Autoimmune Diseases
1.2.4.5. Metabolic Conditions
1.2.4.6. Others
1.2.5. Lyophilized Injectable Drugs Market By End Users
1.2.5.1. Global Lyophilized Injectable Drugs Market Revenue and Growth Rate Comparison By End Users (2015-2026)
1.2.5.2. Global Lyophilized Injectable Drugs Market Revenue Share By End Users in 2017
1.2.5.3. Ambulatory Surgical Centers
1.2.5.4. Hospitals
1.2.5.5. Specialty Clinics
1.2.5.6. Others
1.2.6. Lyophilized Injectable Drugs Market by Geography
1.2.6.1. Global Lyophilized Injectable Drugs Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.6.2. North America Lyophilized Injectable Drugs Market Revenue and Growth Rate (2015-2026)
1.2.6.3. Europe Lyophilized Injectable Drugs Market Revenue and Growth Rate (2015-2026)
1.2.6.4. Asia-Pacific Lyophilized Injectable Drugs Market Revenue and Growth Rate (2015-2026)
1.2.6.5. Latin America Lyophilized Injectable Drugs Market Revenue and Growth Rate (2015-2026)
1.2.6.6. Middle East and Africa (MEA) Lyophilized Injectable Drugs Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porterrsquo;s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Lyophilized Injectable Drugs Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Lyophilized Injectable Drugs Major Manufacturers in 2017
3.3. Ramp;D Status and Technology Source of Global Lyophilized Injectable Drugs Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Lyophilized Injectable Drugs Major Manufacturers in 2017

CHAPTER 4. LYOPHILIZED INJECTABLE DRUGS MARKET BY PACKAGING TYPE

4.1. Global Lyophilized Injectable Drugs Revenue By Packaging Type
4.2. Specialty Packaging
4.2.1. Market Revenue and Growth Rate, 2015 ndash; 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 ndash; 2026 ($Million)
4.3. Point-Of-Care Reconstitution
4.3.1. Market Revenue and Growth Rate, 2015 ndash; 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 ndash; 2026 ($Million)
4.4. Single-Use Vials
4.4.1. Market Revenue and Growth Rate, 2015 ndash; 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 ndash; 2026 ($Million)
4.5. Others
4.5.1. Market Revenue and Growth Rate, 2015 ndash; 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 ndash; 2026 ($Million)

CHAPTER 5. LYOPHILIZED INJECTABLE DRUGS MARKET BY TYPE OF DELIVERY

5.1. Global Lyophilized Injectable Drugs Revenue By Type of Delivery
5.2. Single-step Devices
5.2.1. Market Revenue and Growth Rate, 2015 ndash; 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 ndash; 2026 ($Million)
5.3. Multi-step Devices
5.3.1. Market Revenue and Growth Rate, 2015 ndash; 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 ndash; 2026 ($Million)
5.4. Prefilled Diluent Syringes
5.4.1. Market Revenue and Growth Rate, 2015 ndash; 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 ndash; 2026 ($Million)
5.5. Proprietary Reconstitution Devices
5.5.1. Market Revenue and Growth Rate, 2015 ndash; 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 ndash; 2026 ($Million)

CHAPTER 6. LYOPHILIZED INJECTABLE DRUGS MARKET BY INDICATION

6.1. Global Lyophilized Injectable Drugs Revenue By Indication
6.2. Infectious Diseases
6.2.1. Market Revenue and Growth Rate, 2015 ndash; 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 ndash; 2026 ($Million)
6.3. Autoimmune Diseases
6.3.1. Market Revenue and Growth Rate, 2015 ndash; 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 ndash; 2026 ($Million)
6.4. Metabolic Conditions
6.4.1. Market Revenue and Growth Rate, 2015 ndash; 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 ndash; 2026 ($Million)
6.5. Others
6.5.1. Market Revenue and Growth Rate, 2015 ndash; 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 ndash; 2026 ($Million)

CHAPTER 7. LYOPHILIZED INJECTABLE DRUGS MARKET BY END USERS

7.1. Global Lyophilized Injectable Drugs Revenue By End Users
7.2. Ambulatory Surgical Centers
7.2.1. Market Revenue and Growth Rate, 2015 ndash; 2026 ($Million)
7.2.2. Market Revenue and Forecast, By Region, 2015 ndash; 2026 ($Million)
7.3. Hospitals
7.3.1. Market Revenue and Growth Rate, 2015 ndash; 2026 ($Million)
7.3.2. Market Revenue and Forecast, By Region, 2015 ndash; 2026 ($Million)
7.4. Specialty Clinics
7.4.1. Market Revenue and Growth Rate, 2015 ndash; 2026 ($Million)
7.4.2. Market Revenue and Forecast, By Region, 2015 ndash; 2026 ($Million)
7.5. Others
7.5.1. Market Revenue and Growth Rate, 2015 ndash; 2026 ($Million)
7.5.2. Market Revenue and Forecast, By Region, 2015 ndash; 2026 ($Million)

CHAPTER 8. NORTH AMERICA LYOPHILIZED INJECTABLE DRUGS MARKET BY COUNTRY

8.1. North America Lyophilized Injectable Drugs Market Revenue and Growth Rate, 2015 ndash; 2026 ($Million)
8.2. North America Lyophilized Injectable Drugs Market Revenue Share Comparison, 2015 amp; 2026 (%)
8.3. U.S.
8.3.1. U.S. Lyophilized Injectable Drugs Market Revenue and Forecast By Packaging Type, 2015 ndash; 2026 ($Million)
8.3.2. Market Revenue and Forecast By Type of Delivery, 2015 ndash; 2026 ($Million)
8.3.3. Market Revenue and Forecast By Indication, 2015 ndash; 2026 ($Million)
8.3.4. Market Revenue and Forecast By End-User, 2015 ndash; 2026 ($Million)
8.4. Canada
8.4.1. Market Revenue and Forecast By Packaging Type, 2015 ndash; 2026 ($Million)
8.4.2. Market Revenue and Forecast By Type of Delivery, 2015 ndash; 2026 ($Million)
8.4.3. Market Revenue and Forecast By Indication, 2015 ndash; 2026 ($Million)
8.4.4. Market Revenue and Forecast By End-User, 2015 ndash; 2026 ($Million)
8.5. Mexico
8.5.1. Market Revenue and Forecast By Packaging Type, 2015 ndash; 2026 ($Million)
8.5.2. Market Revenue and Forecast By Type of Delivery, 2015 ndash; 2026 ($Million)
8.5.3. Market Revenue and Forecast By Indication, 2015 ndash; 2026 ($Million)
8.5.4. Market Revenue and Forecast By End-User, 2015 ndash; 2026 ($Million)

CHAPTER 9. EUROPE LYOPHILIZED INJECTABLE DRUGS MARKET BY COUNTRY

9.1. Europe Lyophilized Injectable Drugs Market Revenue and Growth Rate, 2015 ndash; 2026 ($Million)
9.2. Europe Lyophilized Injectable Drugs Market Revenue Share Comparison, 2015 amp; 2026 (%)
9.3. UK
9.3.1. Market Revenue and Forecast By Packaging Type, 2015 ndash; 2026 ($Million)
9.3.2. Market Revenue and Forecast By Type of Delivery, 2015 ndash; 2026 ($Million)
9.3.3. Market Revenue and Forecast By Indication, 2015 ndash; 2026 ($Million)
9.3.4. Market Revenue and Forecast By End-User, 2015 ndash; 2026 ($Million)
9.4. Germany
9.4.1. Market Revenue and Forecast By Packaging Type, 2015 ndash; 2026 ($Million)
9.4.2. Market Revenue and Forecast By Type of Delivery, 2015 ndash; 2026 ($Million)
9.4.3. Market Revenue and Forecast By Indication, 2015 ndash; 2026 ($Million)
9.4.4. Market Revenue and Forecast By End-User, 2015 ndash; 2026 ($Million)
9.5. France
9.5.1. Market Revenue and Forecast By Packaging Type, 2015 ndash; 2026 ($Million)
9.5.2. Market Revenue and Forecast By Type of Delivery, 2015 ndash; 2026 ($Million)
9.5.3. Market Revenue and Forecast By Indication, 2015 ndash; 2026 ($Million)
9.5.4. Market Revenue and Forecast By End-User, 2015 ndash; 2026 ($Million)
9.6. Spain
9.6.1. Market Revenue and Forecast By Packaging Type, 2015 ndash; 2026 ($Million)
9.6.2. Market Revenue and Forecast By Type of Delivery, 2015 ndash; 2026 ($Million)
9.6.3. Market Revenue and Forecast By Indication, 2015 ndash; 2026 ($Million)
9.6.4. Market Revenue and Forecast By End-User, 2015 ndash; 2026 ($Million)
9.7. Rest of Europe
9.7.1. Market Revenue and Forecast By Packaging Type, 2015 ndash; 2026 ($Million)
9.7.2. Market Revenue and Forecast By Type of Delivery, 2015 ndash; 2026 ($Million)
9.7.3. Market Revenue and Forecast By Indication, 2015 ndash; 2026 ($Million)
9.7.4. Market Revenue and Forecast By End-User, 2015 ndash; 2026 ($Million)

CHAPTER 10. ASIA-PACIFIC LYOPHILIZED INJECTABLE DRUGS MARKET BY COUNTRY

10.1. Asia-Pacific Lyophilized Injectable Drugs Market Revenue and Growth Rate, 2015 ndash; 2026 ($Million)
10.2. Asia-Pacific Lyophilized Injectable Drugs Market Revenue Share Comparison, 2015 amp; 2026 (%)
10.3. China
10.3.1. Market Revenue and Forecast By Packaging Type, 2015 ndash; 2026 ($Million)
10.3.2. Market Revenue and Forecast By Type of Delivery, 2015 ndash; 2026 ($Million)
10.3.3. Market Revenue and Forecast By Indication, 2015 ndash; 2026 ($Million)
10.3.4. Market Revenue and Forecast By End-User, 2015 ndash; 2026 ($Million)
10.4. Japan
10.4.1. Market Revenue and Forecast By Packaging Type, 2015 ndash; 2026 ($Million)
10.4.2. Market Revenue and Forecast By Type of Delivery, 2015 ndash; 2026 ($Million)
10.4.3. Market Revenue and Forecast By Indication, 2015 ndash; 2026 ($Million)
10.4.4. Market Revenue and Forecast By End-User, 2015 ndash; 2026 ($Million)
10.5. India
10.5.1. Market Revenue and Forecast By Packaging Type, 2015 ndash; 2026 ($Million)
10.5.2. Market Revenue and Forecast By Type of Delivery, 2015 ndash; 2026 ($Million)
10.5.3. Market Revenue and Forecast By Indication, 2015 ndash; 2026 ($Million)
10.5.4. Market Revenue and Forecast By End-User, 2015 ndash; 2026 ($Million)
10.6. Australia
10.6.1. Market Revenue and Forecast By Packaging Type, 2015 ndash; 2026 ($Million)
10.6.2. Market Revenue and Forecast By Type of Delivery, 2015 ndash; 2026 ($Million)
10.6.3. Market Revenue and Forecast By Indication, 2015 ndash; 2026 ($Million)
10.6.4. Market Revenue and Forecast By End-User, 2015 ndash; 2026 ($Million)
10.7. South Korea
10.7.1. Market Revenue and Forecast By Packaging Type, 2015 ndash; 2026 ($Million)
10.7.2. Market Revenue and Forecast By Type of Delivery, 2015 ndash; 2026 ($Million)
10.7.3. Market Revenue and Forecast By Indication, 2015 ndash; 2026 ($Million)
10.7.4. Market Revenue and Forecast By End-User, 2015 ndash; 2026 ($Million)
10.8. Rest of Asia-Pacific
10.8.1. Market Revenue and Forecast By Packaging Type, 2015 ndash; 2026 ($Million)
10.8.2. Market Revenue and Forecast By Type of Delivery, 2015 ndash; 2026 ($Million)
10.8.3. Market Revenue and Forecast By Indication, 2015 ndash; 2026 ($Million)
10.8.4. Market Revenue and Forecast By End-User, 2015 ndash; 2026 ($Million)

CHAPTER 11. LATIN AMERICA LYOPHILIZED INJECTABLE DRUGS MARKET BY COUNTRY

11.1. Latin America Lyophilized Injectable Drugs Market Revenue and Growth Rate, 2015 ndash; 2026 ($Million)
11.2. Latin America Lyophilized Injectable Drugs Market Revenue Share Comparison, 2015 amp; 2026 (%)
11.3. Brazil
11.3.1. Market Revenue and Forecast By Packaging Type, 2015 ndash; 2026 ($Million)
11.3.2. Market Revenue and Forecast By Type of Delivery, 2015 ndash; 2026 ($Million)
11.3.3. Market Revenue and Forecast By Indication, 2015 ndash; 2026 ($Million)
11.3.4. Market Revenue and Forecast By End-User, 2015 ndash; 2026 ($Million)
11.4. Argentina
11.4.1. Market Revenue and Forecast By Packaging Type, 2015 ndash; 2026 ($Million)
11.4.2. Market Revenue and Forecast By Type of Delivery, 2015 ndash; 2026 ($Million)
11.4.3. Market Revenue and Forecast By Indication, 2015 ndash; 2026 ($Million)
11.4.4. Market Revenue and Forecast By End-User, 2015 ndash; 2026 ($Million)
11.5. Rest of Latin America
11.5.1. Market Revenue and Forecast By Packaging Type, 2015 ndash; 2026 ($Million)
11.5.2. Market Revenue and Forecast By Type of Delivery, 2015 ndash; 2026 ($Million)
11.5.3. Market Revenue and Forecast By Indication, 2015 ndash; 2026 ($Million)
11.5.4. Market Revenue and Forecast By End-User, 2015 ndash; 2026 ($Million)

CHAPTER 12. MIDDLE EAST LYOPHILIZED INJECTABLE DRUGS MARKET BY COUNTRY

12.1. Middle East Lyophilized Injectable Drugs Market Revenue and Growth Rate, 2015 ndash; 2026 ($Million)
12.2. Middle East Lyophilized Injectable Drugs Market Revenue Share Comparison, 2015 amp; 2026 (%)
12.3. Saudi Arabia
12.3.1. Market Revenue and Forecast By Packaging Type, 2015 ndash; 2026 ($Million)
12.3.2. Market Revenue and Forecast By Type of Delivery, 2015 ndash; 2026 ($Million)
12.3.3. Market Revenue and Forecast By Indication, 2015 ndash; 2026 ($Million)
12.3.4. Market Revenue and Forecast By End-User, 2015 ndash; 2026 ($Million)
12.4. UAE
12.4.1. Market Revenue and Forecast By Packaging Type, 2015 ndash; 2026 ($Million)
12.4.2. Market Revenue and Forecast By Type of Delivery, 2015 ndash; 2026 ($Million)
12.4.3. Market Revenue and Forecast By Indication, 2015 ndash; 2026 ($Million)
12.4.4. Market Revenue and Forecast By End-User, 2015 ndash; 2026 ($Million)
12.5. Rest of Middle East
12.5.1. Market Revenue and Forecast By Packaging Type, 2015 ndash; 2026 ($Million)
12.5.2. Market Revenue and Forecast By Type of Delivery, 2015 ndash; 2026 ($Million)
12.5.3. Market Revenue and Forecast By Indication, 2015 ndash; 2026 ($Million)
12.5.4. Market Revenue and Forecast By End-User, 2015 ndash; 2026 ($Million)

CHAPTER 13. AFRICA Lyophilized Injectable Drugs MARKET BY COUNTRY

13.1. Africa Lyophilized Injectable Drugs Market Revenue and Growth Rate, 2015 ndash; 2026 ($Million)
13.2. Africa Lyophilized Injectable Drugs Market Revenue Share Comparison, 2015 amp; 2026 (%)
13.3. South Africa
13.3.1. Market Revenue and Forecast By Packaging Type, 2015 ndash; 2026 ($Million)
13.3.2. Market Revenue and Forecast By Type of Delivery, 2015 ndash; 2026 ($Million)
13.3.3. Market Revenue and Forecast By Indication, 2015 ndash; 2026 ($Million)
13.3.4. Market Revenue and Forecast By End-User, 2015 ndash; 2026 ($Million)
13.4. Egypt
13.4.1. Market Revenue and Forecast By Packaging Type, 2015 ndash; 2026 ($Million)
13.4.2. Market Revenue and Forecast By Type of Delivery, 2015 ndash; 2026 ($Million)
13.4.3. Market Revenue and Forecast By Indication, 2015 ndash; 2026 ($Million)
13.4.4. Market Revenue and Forecast By End-User, 2015 ndash; 2026 ($Million)
13.5. Rest of Africa
13.5.1. Market Revenue and Forecast By Packaging Type, 2015 ndash; 2026 ($Million)
13.5.2. Market Revenue and Forecast By Type of Delivery, 2015 ndash; 2026 ($Million)
13.5.3. Market Revenue and Forecast By Indication, 2015 ndash; 2026 ($Million)
13.5.4. Market Revenue and Forecast By End-User, 2015 ndash; 2026 ($Million)

CHAPTER 14. COMPANY PROFILE

14.1. Schott AG
14.1.1. Company Snapshot
14.1.2. Overview
14.1.3. Financial Overview
14.1.4. Product Portfolio
14.1.5. Key Developments
14.1.6. Strategies
14.2. CIRON Drugs amp; Pharmaceuticals Pvt. Ltd
14.2.1. Company Snapshot
14.2.2. Overview
14.2.3. Financial Overview
14.2.4. Product Portfolio
14.2.5. Key Developments
14.2.6. Strategies
14.3. Mylan N.V.
14.3.1. Company Snapshot
14.3.2. Overview
14.3.3. Financial Overview
14.3.4. Product Portfolio
14.3.5. Key Developments
14.3.6. Strategies
14.4. Baxter
14.4.1. Company Snapshot
14.4.2. Overview
14.4.3. Financial Overview
14.4.4. Product Portfolio
14.4.5. Key Developments
14.4.6. Strategies
14.5. Vetter Pharma
14.5.1. Company Snapshot
14.5.2. Overview
14.5.3. Financial Overview
14.5.4. Product Portfolio
14.5.5. Key Developments
14.5.6. Strategies
14.6. Dickinson and Company
14.6.1. Company Snapshot
14.6.2. Overview
14.6.3. Financial Overview
14.6.4. Product Portfolio
14.6.5. Key Developments
14.6.6. Strategies
14.7. SHL Group
14.7.1. Company Snapshot
14.7.2. Overview
14.7.3. Financial Overview
14.7.4. Product Portfolio
14.7.5. Key Developments
14.7.6. Strategies
14.8. B. Braun Melsungen AG
14.8.1. Company Snapshot
14.8.2. Overview
14.8.3. Financial Overview
14.8.4. Product Portfolio
14.8.5. Key Developments
14.8.6. Strategies
14.9. Jubilant HollisterStier
14.9.1. Company Snapshot
14.9.2. Overview
14.9.3. Financial Overview
14.9.4. Product Portfolio
14.9.5. Key Developments
14.9.6. Strategies

CHAPTER 15. RESEARCH APPROACH

15.1. Research Methodology
15.1.1. Initial Data Search
15.1.2. Secondary Research
15.1.3. Primary Research
15.2. Assumptions and Scope

To Purchase this Premium Report@https://www.acumenresearchandconsulting.com/buy-now/0/1191

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

Editor Details

Last Updated: 28-Mar-2019